Renaissance Capital logo

Biotech CardioMEMS announces terms

April 5, 2007

CardioMEMS, which develops miniature wireless sensors to monitor chronic cardiovascular diseases, announced the terms of its IPO Thursday. The company plans to offer 6 million shares at a price range of $12.00 to $14.00. Banc of America is bookrunning the deal.